MD2518G2 - Медикаментозный препарат для снижения концентрации холестерина в крови - Google Patents
Медикаментозный препарат для снижения концентрации холестерина в крови Download PDFInfo
- Publication number
- MD2518G2 MD2518G2 MDA20030284A MD20030284A MD2518G2 MD 2518 G2 MD2518 G2 MD 2518G2 MD A20030284 A MDA20030284 A MD A20030284A MD 20030284 A MD20030284 A MD 20030284A MD 2518 G2 MD2518 G2 MD 2518G2
- Authority
- MD
- Moldova
- Prior art keywords
- medicamental
- reducing
- blood
- preparation
- cholesterol concentration
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 3
- 235000012000 cholesterol Nutrition 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 108010028554 LDL Cholesterol Proteins 0.000 abstract 1
- 238000008214 LDL Cholesterol Methods 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000001814 pectin Substances 0.000 abstract 1
- 235000010987 pectin Nutrition 0.000 abstract 1
- 229920001277 pectin Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к медицине, в частности к медикаментозным препаратам, которые могут быть использованы для снижения липопротеидов низкой плотности (LDL- холестерина), общего холестерина и триглицеридов в сыворотки крови, что ведет к предупреждению и лечению сердечно-сосудистых заболеваний, вызванных атеросклерозом.Сущность изобретения состоит в том, что медикаментозный препарат содержит соевый белок, яблочный пектин в соотношении 7:1, хлористый кальций и воду, при следующем соотношении компонентов, масс. %:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20030284A MD2518G2 (ru) | 2003-12-09 | 2003-12-09 | Медикаментозный препарат для снижения концентрации холестерина в крови |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20030284A MD2518G2 (ru) | 2003-12-09 | 2003-12-09 | Медикаментозный препарат для снижения концентрации холестерина в крови |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD2518F1 MD2518F1 (en) | 2004-08-31 |
| MD2518G2 true MD2518G2 (ru) | 2005-06-30 |
Family
ID=32906664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20030284A MD2518G2 (ru) | 2003-12-09 | 2003-12-09 | Медикаментозный препарат для снижения концентрации холестерина в крови |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD2518G2 (ru) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2183964C2 (ru) * | 1997-07-30 | 2002-06-27 | Индена С.П.А. | Экстракт сои, способ его приготовления и фармацевтическая композиция |
| AU767245B2 (en) * | 1998-11-25 | 2003-11-06 | Nutri Pharma Asa | Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
-
2003
- 2003-12-09 MD MDA20030284A patent/MD2518G2/ru not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2183964C2 (ru) * | 1997-07-30 | 2002-06-27 | Индена С.П.А. | Экстракт сои, способ его приготовления и фармацевтическая композиция |
| AU767245B2 (en) * | 1998-11-25 | 2003-11-06 | Nutri Pharma Asa | Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| MD2518F1 (en) | 2004-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG152270A1 (en) | Immunemodulating oligosaccharides | |
| Safaeian et al. | Antioxidant effects of bovine lactoferrin on dexamethasone‐induced hypertension in rat | |
| WO2004103294A3 (en) | Methods and compositions for the prevention and treatment of sepsis | |
| EP2322201A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| NO20063328L (no) | Anvendelse av en fettsyresammensetning som innbefatter minst en av EPA og DHA eller kombinasjoner derav | |
| WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| EP1252824A3 (en) | Method for improving bone mineralization | |
| ATE373082T1 (de) | Pre-adipose zelllinien | |
| AU2728900A (en) | Multi-purpose acid compositions | |
| WO2005023185A3 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
| WO2005025615A3 (en) | FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY | |
| DK1643861T3 (da) | Fiber- og kalorierig flydende næringssammensætning til tarmsundhed hos ældre patienter | |
| ATE430572T1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
| CY1108138T1 (el) | Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι | |
| WO2004024072A3 (en) | Novel compositions and methods for the treatment of immune related diseases | |
| WO2004058268A3 (de) | Verwendung von tetrahydrobiopterinderivaten zur behandlung und ernährung von patienten mit aminosäurestoffwechselstörungen | |
| MD2518F1 (en) | Medicamental preparation for reducing the cholesterol concentration in the blood | |
| WO2007097922A3 (en) | Receptor-based blood detoxification system | |
| Matsui et al. | Antihypertensive effect of salt‐free soy sauce, a new fermented seasoning, in spontaneously hypertensive rats | |
| IL175358A0 (en) | 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease | |
| US20030133945A1 (en) | Natural food supplement | |
| WO2002055694A3 (en) | Discriminative nucleic acid analysis using clone sequence signatures | |
| WO2004004649A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| JPS6143978A (ja) | 野菜ジユ−スの消臭方法 | |
| Dargaud et al. | Thrombin Generation and Bleeding Phenotype during Personalized Prophylaxis with Recombinant Human FVIII in Previously Treated Patients with Severe Hemophilia A |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| NF4A | Restoration of lapsed patent for invention | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |